Centessa Pharmaceuticals plc Annual Net Cash Provided by (Used in) Financing Activities in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Centessa Pharmaceuticals plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2019 to 2023.
  • Centessa Pharmaceuticals plc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $10.5M.
  • Centessa Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $21.1M, a 4521% increase from 2022.
  • Centessa Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $457K, a 99.9% decline from 2021.
  • Centessa Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $660M, a 48369% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $21.1M +$20.7M +4521% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $457K -$660M -99.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $660M +$659M +48369% Jan 31, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $1.36M -$7.64M -84.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $9.01M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.